ES2231159T3 - Composiciones terapeuticas que contienen analogos de glutation. - Google Patents
Composiciones terapeuticas que contienen analogos de glutation.Info
- Publication number
- ES2231159T3 ES2231159T3 ES00908420T ES00908420T ES2231159T3 ES 2231159 T3 ES2231159 T3 ES 2231159T3 ES 00908420 T ES00908420 T ES 00908420T ES 00908420 T ES00908420 T ES 00908420T ES 2231159 T3 ES2231159 T3 ES 2231159T3
- Authority
- ES
- Spain
- Prior art keywords
- compound
- lipid
- formulation
- parts
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23853099A | 1999-01-27 | 1999-01-27 | |
US238530 | 1999-01-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2231159T3 true ES2231159T3 (es) | 2005-05-16 |
Family
ID=22898312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES00908420T Expired - Lifetime ES2231159T3 (es) | 1999-01-27 | 2000-01-27 | Composiciones terapeuticas que contienen analogos de glutation. |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1143992B1 (de) |
JP (2) | JP2002535359A (de) |
KR (1) | KR100750842B1 (de) |
CN (1) | CN1185008C (de) |
AT (1) | ATE286741T1 (de) |
AU (1) | AU778340B2 (de) |
CA (1) | CA2360795C (de) |
DE (1) | DE60017359T2 (de) |
ES (1) | ES2231159T3 (de) |
HK (1) | HK1043310B (de) |
PT (1) | PT1143992E (de) |
WO (1) | WO2000044366A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE297945T1 (de) | 1998-04-16 | 2005-07-15 | Teijin Ltd | Glutathionderivate und dazugehörige dosisformen |
US7029695B2 (en) | 2001-07-10 | 2006-04-18 | Telik, Inc. | Therapeutic compositions containing glutathione analogs |
TWI317739B (en) | 2005-01-06 | 2009-12-01 | Telik Inc | Tripeptide and tetrapeptide sulfones |
CN101434645B (zh) * | 2008-12-24 | 2013-01-16 | 中国农业大学 | 一种合成寡肽及其用途 |
JP2015500809A (ja) * | 2011-12-02 | 2015-01-08 | テリク, インコーポレイテッド | 非晶質エザチオスタット非溶媒和物 |
CN108863888B (zh) * | 2018-07-18 | 2021-10-12 | 吉尔生化(上海)有限公司 | 一种(s)-1-(叔丁氧羰基)-5-氧吡咯烷-2-羧酸乙酯的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5786336A (en) * | 1991-04-29 | 1998-07-28 | Terrapin Technologies, Inc. | Target-selective protocols based on mimics |
JP3118869B2 (ja) * | 1991-05-14 | 2000-12-18 | ウェルファイド株式会社 | プロスタグランジン類含有脂肪小体組成物 |
CA2087902C (en) * | 1992-02-05 | 2006-10-17 | Narendra Raghunathji Desai | Liposome compositions of porphyrin photosensitizers |
JP3383704B2 (ja) * | 1993-04-02 | 2003-03-04 | わかもと製薬株式会社 | 安定なリポソーム水分散液 |
WO1995008986A1 (en) * | 1993-09-27 | 1995-04-06 | Smithkline Beecham Corporation | Camptothecin formulations |
JP2891883B2 (ja) * | 1993-11-05 | 1999-05-17 | 学校法人近畿大学 | 抗白内障医薬組成物 |
CA2221568C (en) * | 1995-06-07 | 2010-05-04 | Terrapin Technologies, Inc. | Metabolic effects of certain glutathione analogs |
-
2000
- 2000-01-27 KR KR1020017009543A patent/KR100750842B1/ko not_active IP Right Cessation
- 2000-01-27 CA CA2360795A patent/CA2360795C/en not_active Expired - Fee Related
- 2000-01-27 CN CNB008046522A patent/CN1185008C/zh not_active Expired - Fee Related
- 2000-01-27 ES ES00908420T patent/ES2231159T3/es not_active Expired - Lifetime
- 2000-01-27 AT AT00908420T patent/ATE286741T1/de active
- 2000-01-27 DE DE60017359T patent/DE60017359T2/de not_active Expired - Lifetime
- 2000-01-27 WO PCT/US2000/002297 patent/WO2000044366A2/en active IP Right Grant
- 2000-01-27 AU AU29767/00A patent/AU778340B2/en not_active Ceased
- 2000-01-27 JP JP2000595670A patent/JP2002535359A/ja active Pending
- 2000-01-27 PT PT00908420T patent/PT1143992E/pt unknown
- 2000-01-27 EP EP00908420A patent/EP1143992B1/de not_active Expired - Lifetime
-
2002
- 2002-06-28 HK HK02104871.4A patent/HK1043310B/zh not_active IP Right Cessation
-
2007
- 2007-09-05 JP JP2007229798A patent/JP2007326877A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1342084A (zh) | 2002-03-27 |
WO2000044366A3 (en) | 2000-12-21 |
WO2000044366A2 (en) | 2000-08-03 |
AU778340B2 (en) | 2004-12-02 |
AU2976700A (en) | 2000-08-18 |
KR100750842B1 (ko) | 2007-08-22 |
DE60017359T2 (de) | 2005-12-01 |
JP2007326877A (ja) | 2007-12-20 |
PT1143992E (pt) | 2005-05-31 |
EP1143992A2 (de) | 2001-10-17 |
KR20010101775A (ko) | 2001-11-14 |
HK1043310A1 (en) | 2002-09-13 |
JP2002535359A (ja) | 2002-10-22 |
HK1043310B (zh) | 2005-10-07 |
CA2360795C (en) | 2010-03-23 |
ATE286741T1 (de) | 2005-01-15 |
EP1143992B1 (de) | 2005-01-12 |
CN1185008C (zh) | 2005-01-19 |
DE60017359D1 (de) | 2005-02-17 |
CA2360795A1 (en) | 2000-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7029695B2 (en) | Therapeutic compositions containing glutathione analogs | |
ES2285753T3 (es) | Composicion que forma una emulsion para un compuesto taxoide. | |
ES2366978T3 (es) | Nanocápsulas lipídicas furtivas, procedimientos para su preparación y utilización de las mismas como vehículo para principio(s) activo(s). | |
Yang et al. | Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer | |
ES2657214T3 (es) | Vehículos de fármacos | |
ES2531679T3 (es) | Composiciones para la administración de liberación controlada de péptidos | |
ES2295647T3 (es) | Composiciones de implante farmaceuticas lipofilas, no polimeras, para uso intraocular. | |
US9526787B2 (en) | Sustained-release lipid pre-concentrate of pharmacologically active substance and pharmaceutical composition comprising the same | |
ES2257428T3 (es) | Composiciones farmaceuticas de liberacion sostenida para administracion parenteral de compuestos hidrofilos. | |
ES2385995B2 (es) | Nanocápsulas con cubierta polimérica | |
JP2009507049A (ja) | リン脂質のポリエチレングリコール誘導体に包み込まれたビンカアルカロイド系制癌剤のナノミセル製剤 | |
ES2377352T3 (es) | Nuevas composiciones a base de taxoides | |
WO2023015904A1 (zh) | 一种新型阳离子脂质化合物 | |
WO2023024513A1 (zh) | 新型阳离子脂质化合物 | |
ES2287980T3 (es) | Composicion farmaceutica placebo liofilizable destinada a imitar un medicamento, en particular a base de proteinas o e polipeptidos. | |
ES2231159T3 (es) | Composiciones terapeuticas que contienen analogos de glutation. | |
WO2019122220A1 (en) | Liposomes comprising sphingomyelin | |
ES2303642T3 (es) | Formulaciones semi-solidas para la administracion oral de taxoides. | |
CA3236290A1 (en) | Formulated and/or co-formulated nanocarriers compositions containing immunogenic cell death (icd) inducing prodrugs useful in the treatment of cancer and methods thereof | |
CN115120611A (zh) | 一种no供体型胶束组合物及其制备方法与应用 | |
US11801304B2 (en) | Formulated and/or co-formulated liposome compositions containing TFGB antagonist prodrugs useful in the treatment of cancer and methods thereof | |
ES2269200T3 (es) | Formulacion de liposomas de dimaleato de 6,9-bis-((2-aminoetil)-amino)benzo(g)isoquinolin-5,10-diona. | |
US11833209B2 (en) | Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof | |
Javaid et al. | Exploring Niosomes: A Comprehensive Review of their Structure, Formulation, and Biomedical Applications | |
WO2023024512A1 (zh) | 新型阳离子脂质化合物 |